Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Canadian Multicentre Osteoporosis Study (CaMos)
Autore:
Tenenhouse, A; Krieger, N; Hanley, D;
Indirizzi:
Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada Montreal Gen Hosp Montreal PQ Canada H3G 1A4 Montreal, PQ H3G 1A4, Canada Univ Toronto, Fac Med, Toronto, ON, Canada Univ Toronto Toronto ON Canada niv Toronto, Fac Med, Toronto, ON, Canada Univ Calgary, Fac Med, Calgary, AB, Canada Univ Calgary Calgary AB Canada niv Calgary, Fac Med, Calgary, AB, Canada
Titolo Testata:
DRUG DEVELOPMENT RESEARCH
fascicolo: 3, volume: 49, anno: 2000,
pagine: 201 - 205
SICI:
0272-4391(200003)49:3<201:CMOS(>2.0.ZU;2-K
Fonte:
ISI
Lingua:
ENG
Soggetto:
BONE-DENSITY; VERTEBRAL FRACTURES; HIP FRACTURE; WOMEN; EPIDEMIOLOGY; POPULATION; PREVALENCE; MEN;
Keywords:
osteoporosis; pharmacoepidemiology; multicenter study;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Life Sciences
Citazioni:
19
Recensione:
Indirizzi per estratti:
Indirizzo: Tenenhouse, A Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada Montreal Gen Hosp 1650 Cedar Ave Montreal PQ Canada H3G 1A4
Citazione:
A. Tenenhouse et al., "Canadian Multicentre Osteoporosis Study (CaMos)", DRUG DEV R, 49(3), 2000, pp. 201-205

Abstract

The Canadian Multicentre Osteoporosis Study (CaMos) is a five-year prospective study of the skeletal health of a randomly selected population of women and men greater than or equal to 25 years from nine centres across Canada. it will assess the relationship between low-trauma fractures and various characteristics of bone including Dual Energy X-ray Absorptiometry (DEXA) and risk factors. The immediate objectives are to determine the dimensions of osteoporosis and fracture in Canada and to determine the environmental risk factors for these diseases. The long-term objectives are to develop methods for the accurate detection of those at increased risk to fracture and to develop strategies for fracture prevention. The study started in lan. 1996 and subject recruitment was complete by Sept. 1997. Canadian reference standards for DEXA have been established and with these the prevalence of osteoporosis, as defined by WHO, was estimated. Approximately 15% of women and 5% of men over age 50 years have osteoporosis and 55% of women and 35% of men have osteopenia. From spine x-rays it wasfound that >25% of Canadian women and men over age 50 years have verebral deformities. The five year follow-up of all CaMos subjects will begin July 2000 and is scheduled to be completed in Sept. 2002. Analysis of the baseline and annual follow-up data is currently underway. There is every indication from the results to date that our short and long-term objectives will be met. Drug Dev. Res. 49:201-205, 2000. (C) 2000 Wiley-Liss, Inc.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/01/20 alle ore 10:18:35